2 stories mentioning CBIOUpdated 49d ago
Every FINWIRES story that references CBIO, newest first.
Crescent Biopharma (CBIO) shares fell 5.4% on Monday after HC Wainwright downgraded the stock to neutral from buy.Trading volume stood at around 254,676 shares compared with a daily average of 264,600.Price: $19.53, Change: $-1.12, Percent Change: -5.42%
Crescent Biopharma (CBIO) has an average rating of buy and mean price target of $29.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
